NASDAQ:ICUI

ICU Medical Stock Forecast, Price & News

$205.28
+0.38 (+0.19 %)
(As of 06/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$203.40
$206.30
50-Day Range
$190.83
$215.73
52-Week Range
$170.57
$227.07
Volume102,436 shs
Average Volume120,580 shs
Market Capitalization$4.36 billion
P/E Ratio47.30
Dividend YieldN/A
Beta0.59
30 days | 90 days | 365 days | Advanced Chart
Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.


ICU Medical logo

About ICU Medical

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.58 out of 5 stars

Medical Sector

454th out of 2,100 stocks

Surgical & Medical Instruments Industry

41st out of 174 stocks

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

Is ICU Medical a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view top-rated stocks.

What stocks does MarketBeat like better than ICU Medical?

Wall Street analysts have given ICU Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ICU Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) announced its quarterly earnings data on Thursday, May, 6th. The medical instruments supplier reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.32 by $0.02. The medical instruments supplier earned $318.05 million during the quarter, compared to analyst estimates of $304.20 million. ICU Medical had a net margin of 7.44% and a trailing twelve-month return on equity of 8.69%.
View ICU Medical's earnings history
.

How has ICU Medical's stock been impacted by COVID-19 (Coronavirus)?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ICUI stock has increased by 13.7% and is now trading at $205.28.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for ICUI?

2 brokers have issued 1-year price objectives for ICU Medical's stock. Their forecasts range from $236.00 to $245.00. On average, they expect ICU Medical's stock price to reach $240.50 in the next twelve months. This suggests a possible upside of 17.2% from the stock's current price.
View analysts' price targets for ICU Medical
or view top-rated stocks among Wall Street analysts.

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, CEO & Chairman (Age 49, Pay $1.31M)
  • Mr. Brian Michael Bonnell, CFO & Treasurer (Age 47, Pay $726.99k)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 52, Pay $684.83k)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel, Sec. & Compliance Officer (Age 46, Pay $492.82k)
  • Mr. Kevin J. McGrody, Chief Accounting Officer

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical CEO Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among ICU Medical's employees.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), The Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (12.15%), Janus Henderson Group PLC (11.43%), BlackRock Inc. (8.23%), Nuance Investments LLC (4.88%), JPMorgan Chase & Co. (4.29%) and Victory Capital Management Inc. (2.09%). Company insiders that own ICU Medical stock include Elisha W Finney, George A Lopez, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Nitorum Capital L.P., Price T Rowe Associates Inc. MD, Russell Investments Group Ltd., Kennedy Capital Management Inc., Redmile Group LLC, State of Tennessee Treasury Department, and Prudential Financial Inc.. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
or view top insider-selling stocks.

Which major investors are buying ICU Medical stock?

ICUI stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., JPMorgan Chase & Co., Nuance Investments LLC, BlackRock Inc., Schroder Investment Management Group, Victory Capital Management Inc., BNP Paribas Arbitrage SA, and Brown Advisory Inc..
View insider buying and selling activity for ICU Medical
or or view top insider-buying stocks.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $205.28.

How much money does ICU Medical make?

ICU Medical has a market capitalization of $4.36 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $86.87 million in net income (profit) each year or $6.13 on an earnings per share basis.

How many employees does ICU Medical have?

ICU Medical employs 7,900 workers across the globe.

When was ICU Medical founded?

ICU Medical was founded in 1984.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

Where are ICU Medical's headquarters?

ICU Medical is headquartered at 951 CALLE AMANECER, SAN CLEMENTE CA, 92763.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]


This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.